Trial Profile
A phase I/II, open-label study to evaluate the safety, tolerance and pharmacokinetics of stavudine (d4T) in combination with lamivudine (3TC) in HIV-infected pregnant women and their infants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary) ; Stavudine (Primary) ; Zidovudine
- Indications HIV infections
- Focus Adverse reactions
- 20 Oct 2005 New trial record.